Carlson Sean L, Mathew Liya, Savage Michael, Kok Klaartje, Lindsay James O, Munro Carol A, McCarthy Neil E
Centre for Immunobiology, The Blizard Institute, Queen Mary University of London, London E1 2AT, UK.
Gastroenterology Department, Royal London Hospital, Barts Health NHS Trust, London E1 1BB, UK.
J Fungi (Basel). 2023 Nov 14;9(11):1105. doi: 10.3390/jof9111105.
The gut microbiome is a diverse microbial community composed of bacteria, viruses, and fungi that plays a major role in human health and disease. Dysregulation of these gut organisms in a genetically susceptible host is fundamental to the pathogenesis of inflammatory bowel disease (IBD). While bacterial dysbiosis has been a predominant focus of research for many years, there is growing recognition that fungal interactions with the host immune system are an important driver of gut inflammation. is likely the most studied fungus in the context of IBD, being a near universal gut commensal in humans and also a major barrier-invasive pathogen. There is emerging evidence that intra-strain variation in virulence factors exerts a critical influence on IBD pathophysiology. In this review, we describe the immunological impacts of variations in colonisation, morphology, genetics, and proteomics in IBD, as well as the clinical and therapeutic implications.
肠道微生物群是一个由细菌、病毒和真菌组成的多样化微生物群落,在人类健康和疾病中发挥着重要作用。在遗传易感性宿主中,这些肠道微生物的失调是炎症性肠病(IBD)发病机制的基础。虽然细菌失调多年来一直是研究的主要焦点,但人们越来越认识到真菌与宿主免疫系统的相互作用是肠道炎症的重要驱动因素。在IBD的背景下,可能是研究最多的真菌,它是人类近乎普遍的肠道共生菌,也是一种主要的突破屏障的病原体。新出现的证据表明,毒力因子的菌株内变异对IBD的病理生理学产生关键影响。在这篇综述中,我们描述了在IBD中,其定植、形态、遗传学和蛋白质组学变化的免疫学影响,以及临床和治疗意义。